In gliomas, a downregulation of LACTB leads to an increase in cancer cell proliferation and angiogenesis, corresponding to a poor prognosis in patients, while its overexpression does the opposite by inhibiting PCNA, MMP2, MMP9, and VEGF, which are key regulators in glioma cell proliferation [175]. Here, MMP2 is linked to glioma.